The biopharmaceutical industry is currently navigating through turbulent waters as a series of layoffs and strategic overhauls ripple across the sector. The urgency that once underscored the COVID-19 pandemic has given way to a new reality where pharmaceutical giants are reassessing their
April 29, 2024Ireland's biopharmaceutical industry is on the verge of substantial expansion, with an expected increase of 21,000 jobs by 2027. The Expert Group on Future Skills Needs (EGFSN) has highlighted the essential role of the biopharma sector in bolstering the national economy. Despite the optimistic
April 29, 2024The University of Delaware is making major strides in the biopharma sector by launching the new SABRE Center. Backed by $45 million in federal funding, including $10 million from the American Rescue Plan, this 90,000-square-foot hub is set to propel the university into a leader in biopharmaceutical
April 26, 2024Streamlining for Efficiency Reducing Workforce in Switzerland and the US In an ongoing effort to refine its operations, Novartis has announced a significant reduction in its workforce that will see between 400 and 440 jobs eliminated in Switzerland, specifically targeting operational and
April 3, 2024